• Często zadawane pytania
  • Słownik
Więcej

Często zadawane pytania

Dlaczego do badania bezpieczeństwa nowej terapii wykorzystuje się modele zwierzęce?
Dlaczego niektóre schorzenia są bardziej odpowiednie do terapii genowej i komórkowej niż inne?
Czym są ATMP i gdzie mają zastosowanie w terapii genowej i komórkowej?
Czym jest terapia genowa i komórkowa?

Zobacz wszystkie często zadawane pytania

Więcej

Słownik

Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising 
Antibody
Antigen
Base editors

Zobacz kompletny słowniczek

ATMP Engage PPI Directory

The PPI Directory contains patient and public involvement (PPI) resources for developers of cell and gene therapies, including toolkits, guidelines, advice, templates and case studies.

PPI Directory

PPI Themes
Research Field
Organisation Type
Development Stage
Audience
Country
Content Type
    Showing 5 of 174 results.
    Page 1 of 35

    EUPATIConnect

    Bringing EUPATI Patient Experts and researchers together
    Visit this Resource

    Organisation Type

    • Third Sector/Charity

    Development Stage

    • Identifying/Prioritising Patient Need
    • Research and Clinical Development

    Audience

    • Researchers/Developers
    • Public/Patients
    • Industry

    Country

    • Europe

    Content Type

    • Resource

    HTA4Patients

    EUPATI HTA4Patients -Bringing Health Technology Assessment (HTA) closer to patients
    Visit this Resource

    Organisation Type

    • Third Sector/Charity

    Development Stage

    • Health Technology Assessment

    Audience

    • Public/Patients
    • Charity Sector

    Country

    • Europe

    Content Type

    • Resource

    Getting involved in EMA activities as a patient, consumer or carer

    Patients, consumers and carers are involved in a wide range of European Medicines Agency (EMA) activities
    Visit this Resource

    Research Field

    • General
    • Pharmaceutical
    • ATMP/Gene Therapy Development

    Organisation Type

    • Regulatory Body

    Development Stage

    • Research and Clinical Development
    • Regulatory Approval
    • Health Technology Assessment

    Audience

    • Researchers/Developers
    • Public/Patients

    Country

    • Europe

    Content Type

    • Resource

    Patient Engagement Resource Centre

    The Patient Engagement Resource Centre is developed by EATRIS (the European Infrastructure for Translational Medicine) and EPF (European Patients’ Forum), together with affiliated partner EATG (European Aids Treatment Group).
    Aiming at translational researchers, this platform contains selected relevant public resources to help researchers understand the basics of patient engagement, and guide them through the different phases of patient engagement, from planning to conducting and evaluating.
    Visit this Resource

    Research Field

    • General
    • Biomedical Lab
    • Pharmaceutical
    • ATMP/Gene Therapy Development

    Organisation Type

    • Third Sector/Charity
    • Other Organisation

    Development Stage

    • Identifying/Prioritising Patient Need
    • Research and Clinical Development

    Audience

    • Researchers/Developers
    • Charity Sector
    • Industry

    Country

    • Europe

    Content Type

    • Repository

    Patient involvement in the Committee for Advanced Therapies

    Presentation slides on patient involvement in the Committee for Advanced Therapies (CAT) at the European Medicines Agency (EMA)
    Visit this Resource

    Research Field

    • Pharmaceutical
    • ATMP/Gene Therapy Development

    Organisation Type

    • Regulatory Body

    Development Stage

    • Research and Clinical Development
    • Regulatory Approval
    • Health Technology Assessment

    Audience

    • Researchers/Developers
    • Public/Patients
    • Other groups

    Country

    • Europe

    Content Type

    • Resource
    Powrót do góry strony